PDF
(Download)
|
- Ginkgo (Ginkgo biloba)
- Working Memory
- Cognition
| Date:
02-15-2012 | HC# 111154-442
|
Re: Ginkgo Extract Improves Working Memory while Attenuating Brain Electrophysiology
Silberstein
RB, Pipingas A, Song J, Camfield DA, Nathan PJ, Stough C. Examining brain-cognition effects of Ginkgo biloba extract: brain activation
in the left temporal and left prefrontal cortex in an object working memory
task. Evid Based Complement Alternat Med.
2011;2011:164139. doi:10.1155/2011/164139.
Ginkgo (Ginkgo biloba) extract is used to
improve cognition. Numerous studies have shown that it improves working memory.
Working memory is a type of short-term memory; it is a system for temporarily
storing and managing information to complete a complex task. The mechanism by
which ginkgo improves working memory is unknown. The purpose of this randomized,
double-blind, crossover study was to better understand the neurophysiology of
this action by monitoring brain steady state visually evoked potentials (SSVEP)
while subjects completed a working memory task known to be improved by ginkgo
treatment.
Nineteen
right-handed subjects between 50 and 61 years of age and with normal,
uncorrected vision participated in this study conducted at Swinburne
University, Victoria, Australia. Exclusion criteria included past history of
head injury requiring hospitalization, intellectual developmental disability,
neurological or psychiatric illness, epilepsy, and/or a history of substance
abuse. Subjects were randomly selected to be treated with placebo or 80 mg (2
tablets) ginkgo extract (Ginkgoforte®; Blackmores; Warriewood, NSW,
Australia) daily for 14 days. Each tablet contained 40 mg of ginkgo extract
(equivalent to 2 g dry leaf), standardized to 10.7 mg ginkgo flavonol
glycosides and 2.7 mg ginkgolides and bilobalide. Following 14 days of treatment, there was a
14-day washout period, after which the subjects were crossed-over to the other treatment.
Steady state topography (SST) was measured at the two baselines and after 14 days
of each treatment. During each SST recording session, subjects performed 3
cognitive activation tasks. Only the working memory task was reported in this
article. The working memory task involved briefly showing the subject 1 or 2 irregular
polygons on a screen and then, after a 3-second hold period, presenting an
irregular object. The subject had to decide if it was a match to the polygon on
the screen. Reaction time and accuracy were recorded. The brain electrical
activity was recorded from 64 scalp electrodes.
There was a
significant, modest increase in accuracy after ginkgo treatment (76.8%
accuracy) compared with after placebo treatment (71.7% accuracy) (P = 0.037).
There was no significant difference in reaction time between ginkgo and placebo
treatment. Compared with placebo, ginkgo significantly increased the SSVEP
amplitude at the frontal, prefrontal, and occipital [Note: The article says
occipital in the abstract and at the beginning of 3.2.3, but states parietal in
3.2.2.] sites, and increased the SSVEP latency at the left temporal, left prefrontal,
and midline frontal sites.
The authors
speculate that the increase in SSVEP amplitude and the improvement in
performance were related. The reason that an increase in amplitude is
associated with an increase in performance is unclear. The increase in SSVEP
represents lower levels of cortical activity or "cortical idling,"
indicating reduced cognitive effort. Alternately, the increase in SSVEP could
indicate more efficient neural processing.
The SSVEP
latency increase (slower processing) indicates reduced synaptic excitation or
increased inhibition. The effects of the Alzheimer's disease drug physostigmine
are mediated by cholinergic processes, and other researchers have shown that
during the working memory task physostigmine improves performance (reaction
time) and is associated with reduced brain activity in the left temporal and
prefrontal sites. Therefore, the authors hypothesize that the cognitive-enhancing
effects of ginkgo were mediated in part by cholinergic mechanisms.
The authors
conclude that the improvements in ginkgo-associated working memory are attributed
to enhanced synaptic inhibition, which may be working through a cholinergic
mechanism.
The brains
of cognitively impaired individuals differ from the brains of healthy ones. Therefore,
this study needs to be repeated in other populations to confirm the findings.
—Heather S. Oliff, PhD
|